Experts share here what they take away from the Conference on Retroviruses and Opportunistic Infections (CROI) each year and ...
allAfrica.com on MSN4d
Africa: A Jab That Could Protect Against HIV for a Year At a Time, and Other Highlights From Major ConferenceA single shot of a new formulation of the antiretroviral drug lenacapavir could potentially provide protection against HIV ...
El Mundo on MSN13d
New advance against HIV: a single annual injection against the infectionData from a very early-phase trial shows that the drug is safe and remains in the body for up to 56 weeks. From two ...
A slow immune response to SARS-CoV-2 infection, delayed viral clearance, and viral rebound can all increase a person’s risk ...
In 2020, the Conference on Retroviruses and Opportunistic Infections (CROI) was the first scientific conference to move from in-person to virtual due to the COVID-19 pandemic. On the fifth anniversary ...
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of late-breaking data and multiple oral presentations from its innovative HIV treatment portfolio and pipeline at the Conference ...
Gilead Sciences, Inc. (NASDAQ:GILD) presented data from its HIV treatment portfolio and pipeline at the Conference on ...
Data from two studies suggest that a once-daily combination therapy of doravirine and islatravir was noninferior to current, ...
Theratechnologies (THTX) presented data highlighting the limitations of using body mass index alone in assessing cardiovascular risk in people ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback